A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
~31 mi.
(Paso de las Limas,
Mexico,
+192 more cities)
COI Centro Oncológico Intl. S.A.P.I. de C.V._ S.F.